Estuary Biotherapeutics, Inc. is a biotechnology company focused on developing treatments, specifically "All in for ADPKD," led by CEO and co-founder Wayne Sackett and located in Menlo Park.
Subscribe to see Estuary Biotherapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Estuary Biotherapeutics, Inc. is a company headquartered in United States. Its most recent funding round, Series A, raised $93M in October 2026. Xcout tracks 4 named people at Estuary Biotherapeutics, Inc., including Wayne E. Sackett (Executive Officer).
As of 17 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $93M | 6 named | |
| SEC Form D filing | $40.7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Estuary Biotherapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Gilva Therapeutics Inc. is a biopharmaceutical company headquartered in Taipei City, Taiwan, focusing on addressing significant unmet medical needs such as ADPKD. The company sponsors early-stage clinical evaluations, including Phase 1 studies for treatments like GV-100.
Goldfinch Bio, Inc. is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing precision medicines for the treatment of kidney diseases.
ENYO Pharma is a clinical-stage biopharmaceutical company that develops therapeutics for patients with impaired kidney function. Its lead compound, Vonafexor, is a small molecule currently in Phase 2 development to treat rare kidney diseases such as Alport syndrome and chronic kidney disease.
Chinook Therapeutics U.S., Inc. was a biotechnology company with offices in Seattle, Washington, that focused on the discovery and development of precision medicines for kidney diseases.
R1 Therapeutics is a renal-focused biotech company developing innovative, first-in-class, category-defining therapeutics for patients with kidney disease. Headquartered in San Francisco with additional offices in San Diego and Raleigh, the company started with lead asset AP306.
Santa Barbara Nutrients, Inc. is a public benefit corporation incorporated in Delaware and based in Santa Barbara, California, focused on developing nutritional products like KetoCitra for kidney health and managing polycystic kidney disease.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Estuary Biotherapeutics, Inc.? Suggest a correction · Work at Estuary Biotherapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.